Company: NCEL
Filing Date: 2025-10-17
Form Type: POS AM
Source: 0001213900-25-099986
Chunk: 29

Company: NewcelX Ltd.
Filing Date: 2025-10-17
Form: POS AM
Chunk 29
---
, and cannot generate significant recurring revenues, profit and cash flow provided by operating activity, Kadimastem anticipates that they will be obtained through the incurrence of additional indebtedness, additional equity financings or a combination of these potential sources of funds. However, such financing may not be available on favorable terms, or at all. In particular, the repercussions from inflation, economic uncertainty, as well as the war between Russia and the Ukraine and Israel, Hamas and Hezbollah, has resulted in, and may continue to result in, significant disruption of global financial markets, reducing Kadimastem’s ability to access capital. If Kadimastem is unable to raise additional funds when desired, Kadimastem’s business, financial condition and results of operations could be adversely affected. Cash and Cash Equivalents The balance of cash and cash equivalents for the six months ended June 30, 2025, was $298,932, representing a decrease of $249,352 compared to $548,284 for the six months ended June 30, 2024. The decrease is primarily due to the cash used in operation activities. The balance of cash and cash equivalents for the year ended December 31, 2024, was $650,398, representing a decrease of $495,177, compared to $1,145,575 for the year ended December 31, 2023. The decrease is primarily due to the receipt of $1.7 million under a convertible loan agreement between Kadimastem and few shareholders, Alpha and Mr. Julien Ruggieri, of which $1.25 million was received on December 21, 2023, and $450,000 was received on April 20, 2024, and net cash used in operating activities for the year 2024 in the amount of $705,483. Net Cash Used in Operating Activities Net cash used in operating activities for the six months ended June 30, 2025, was $602,695, representing a decrease of $160,982, compared to $763,677 for the six months ended June 30, 2024. This decrease is mainly due to the reduction of general and administration expenses (excluding the cash -basedcompensation). Net cash used in operating activities for the year ended December 31, 2024, was $705,483, representing a decrease of $2,290,330 compared to $2,995,813 for the year ended December 31, 2023. This decrease